Marshall Wace’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-50,900
| Closed | -$93.1K | – | 2793 |
|
|
2024
Q4 | $93.1K | Sell |
50,900
-2,071,020
| -98% | -$3.79M | ﹤0.01% | 2276 |
|
|
2024
Q3 | $3.61M | Buy |
2,121,920
+510,620
| +32% | +$868K | ﹤0.01% | 1037 |
|
|
2024
Q2 | $2.21M | Buy |
1,611,300
+1,117,966
| +227% | +$1.53M | ﹤0.01% | 1201 |
|
|
2024
Q1 | $1.85M | Buy |
493,334
+349,246
| +242% | +$1.31M | ﹤0.01% | 1221 |
|
|
2023
Q4 | $1.41M | Sell |
144,088
-344,380
| -71% | -$3.38M | ﹤0.01% | 1123 |
|
|
2023
Q3 | $4.08M | Buy |
+488,468
| New | +$4.08M | 0.01% | 838 |
|
|
2023
Q2 | – | Sell |
-11,500
| Closed | -$133K | – | 2370 |
|
|
2023
Q1 | $133K | Sell |
11,500
-63,600
| -85% | -$736K | ﹤0.01% | 1967 |
|
|
2022
Q4 | $614K | Sell |
75,100
-14,500
| -16% | -$119K | ﹤0.01% | 1756 |
|
|
2022
Q3 | $520K | Buy |
+89,600
| New | +$520K | ﹤0.01% | 2029 |
|
|
2020
Q4 | – | Sell |
-146,005
| Closed | -$1.44M | – | 1964 |
|
|
2020
Q3 | $1.44M | Sell |
146,005
-2,256
| -2% | -$22.3K | 0.01% | 864 |
|
|
2020
Q2 | $512K | Sell |
148,261
-38,356
| -21% | -$132K | ﹤0.01% | 1163 |
|
|
2020
Q1 | $571K | Sell |
186,617
-101,027
| -35% | -$309K | 0.01% | 941 |
|
|
2019
Q4 | $1.48M | Sell |
287,644
-380,493
| -57% | -$1.96M | 0.01% | 849 |
|
|
2019
Q3 | $3.45M | Buy |
668,137
+396,180
| +146% | +$2.04M | 0.03% | 571 |
|
|
2019
Q2 | $1.65M | Sell |
271,957
-685,257
| -72% | -$4.14M | 0.01% | 799 |
|
|
2019
Q1 | $6.92M | Buy |
957,214
+337,213
| +54% | +$2.44M | 0.07% | 363 |
|
|
2018
Q4 | $4.59M | Buy |
+620,001
| New | +$4.59M | 0.05% | 462 |
|